NASDAQ : LAB
Standard BioTools Inc. — Financial statements
Healthcare · Medical Devices · United States
Last price 0.61 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 239.47M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Standard BioTools Inc. (LAB) reported revenue of 84.60M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 84.60M | 85.33M | 91.01M | 106.34M | 97.95M | 128.85M |
| Other Revenue | 1.73M | |||||
| Revenue | 84.60M | 85.33M | 91.01M | 106.34M | 97.95M | 130.58M |
| Cost of Revenue | 41.89M | 42.79M | 46.12M | 55.89M | 60.90M | 99.15M |
| Gross Profit | 42.71M | 42.54M | 44.88M | 50.45M | 37.05M | 31.43M |
| Selling, General & Admin | 86.93M | 109.86M | 103.06M | 87.54M | 102.28M | 98.89M |
| Research & Development | 18.42M | 25.99M | 28.83M | 25.95M | 33.86M | |
| Operating Expenses | 105.34M | 135.85M | 131.89M | 113.49M | 136.14M | 98.89M |
| Operating Income | -62.64M | -93.31M | -87.01M | -63.04M | -99.09M | -67.46M |
| Interest Expense | -26.00K | -26.00K | -3.32M | -4.57M | -4.33M | -3.82M |
| Interest & Investment Income | 11.94M | 9.18M | 20.20M | 5.57M | 2.23M | |
| Other Non Operating Income (Expenses) | -3.42M | 5.00M | -5.01M | 1.39M | -60.90M | 7.62M |
| EBT Excluding Unusual Items | -54.15M | -79.16M | -75.13M | -60.64M | -162.09M | -63.66M |
| Merger & Restructuring Charges | -32.83M | -16.94M | -40.48M | -13.56M | -13.59M | |
| Gain (Loss) on Sale of Investments | -602.00K | -602.00K | ||||
| Asset Writedown | -3.53M | |||||
| Other Unusual Items | -3.40M | 25.21M | -13.72M | |||
| Pretax Income | -90.98M | -96.70M | -90.40M | -74.20M | -192.93M | -63.66M |
| Income Tax Expense | -37.05M | -37.88M | 542.00K | 452.00K | -2.83M | -4.42M |
| Earnings From Continuing Operations | -53.93M | -58.83M | -90.94M | -74.66M | -190.10M | -59.24M |
| Earnings From Discontinued Operations | 138.84M | -16.07M | -47.95M | |||
| Net Income | 84.91M | -74.90M | -138.88M | -74.66M | -190.10M | -59.24M |
| Preferred Dividends & Other Adjustments | 46.01M | |||||
| Net Income to Common | 84.91M | -74.90M | -184.90M | -74.66M | -190.10M | -59.24M |
| Shares Outstanding (Basic) | 386.71M | 381.62M | 353.25M | 79.16M | 78.31M | 75.79M |
| Shares Outstanding (Diluted) | 386.71M | 381.62M | 353.25M | 79.16M | 78.31M | 75.79M |
| EPS (Basic) | 0.22 | -0.20 | -0.52 | -0.94 | -2.43 | -0.78 |
| EPS (Diluted) | 0.22 | -0.20 | -0.52 | -0.94 | -2.43 | -0.78 |
| Free Cash Flow | -82.58M | -82.65M | -151.81M | -46.12M | -93.19M | -57.33M |
| Free Cash Flow Per Share | -0.21 | -0.22 | -0.43 | -0.58 | -1.19 | -0.76 |
| Gross Margin | 50.48% | 49.86% | 49.32% | 47.44% | 37.83% | 24.07% |
| Operating Margin | -74.04% | -109.34% | -95.60% | -59.28% | -101.17% | -51.66% |
| Profit Margin | 100.36% | -87.77% | -203.17% | -70.20% | -194.08% | -45.36% |
| Free Cash Flow Margin | -97.61% | -96.85% | -166.81% | -43.37% | -95.15% | -43.90% |
| EBITDA | -53.07M | -82.33M | -70.14M | -47.86M | -84.06M | -63.81M |
| EBITDA Margin | -62.73% | -96.48% | -77.08% | -45.01% | -85.82% | -48.86% |
| D&A For EBITDA | 9.56M | 10.98M | 16.86M | 15.18M | 15.03M | 3.65M |
| EBIT | -62.64M | -93.31M | -87.01M | -63.04M | -99.09M | -67.46M |
| EBIT Margin | -74.04% | -109.34% | -95.60% | -59.28% | -101.17% | -51.66% |
| Revenue as Reported | 84.60M | 85.33M | 91.01M | 106.34M | 97.95M | 130.58M |
| Advertising Expenses | 2.20M | 2.60M | 2.00M | 3.40M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 270.03M | 120.86M | 166.73M | 51.70M | 81.31M | 28.45M |
| Short-Term Investments | 206.69M | 66.71M | 126.15M | 63.19M | 84.47M | |
| Cash & Short-Term Investments | 476.72M | 187.57M | 292.87M | 114.89M | 165.78M | 28.45M |
| Receivables | 15.75M | 13.43M | 14.74M | 19.66M | 17.28M | 18.32M |
| Inventory | 17.10M | 19.98M | 20.74M | 20.53M | 21.47M | 20.82M |
| Prepaid Expenses | 7.30M | 4.87M | 4.56M | 3.13M | 4.28M | 4.45M |
| Restricted Cash | 16.00K | |||||
| Other Current Assets | 228.41M | 42.96M | ||||
| Total Current Assets | 516.87M | 454.26M | 375.88M | 158.22M | 208.81M | 72.07M |
| Property, Plant & Equipment | 39.55M | 46.01M | 49.34M | 54.85M | 59.53M | 65.15M |
| Long-Term Investments | 67.28M | 25.70M | ||||
| Goodwill | 106.32M | 106.25M | 106.38M | |||
| Other Intangible Assets | 1.40M | 13.18M | 29.18M | |||
| Long-Term Deferred Tax Assets | 264.00K | 38.63M | 138.00K | 231.00K | 183.00K | |
| Other Long-Term Assets | 3.26M | 3.15M | 186.98M | 2.29M | 2.30M | 2.25M |
| Total Assets | 627.22M | 567.75M | 612.35M | 323.07M | 390.31M | 275.21M |
| Accounts Payable | 9.55M | 5.41M | 5.05M | 9.24M | 7.91M | 10.60M |
| Accrued Expenses | 23.91M | 25.24M | 16.75M | 16.09M | 7.52M | 13.59M |
| Short-Term Debt | 6.84M | |||||
| Current Portion of Long-Term Debt | 59.53M | 2.08M | ||||
| Current Portion of Leases | 5.62M | 5.49M | 4.81M | 4.32M | 3.68M | 3.05M |
| Current Income Taxes Payable | 3.03M | 1.44M | ||||
| Current Unearned Revenue | 12.02M | 41.99M | 13.80M | 15.22M | 14.44M | 15.48M |
| Other Current Liabilities | 2.67M | 30.17M | 25.49M | 4.93M | 6.37M | |
| Total Current Liabilities | 56.80M | 108.31M | 65.89M | 109.33M | 43.44M | 49.57M |
| Long-Term Debt | 299.00K | 299.00K | 299.00K | 3.98M | 62.81M | 64.21M |
| Long-Term Leases | 22.17M | 25.04M | 25.59M | 30.37M | 34.08M | 37.55M |
| Long-Term Unearned Revenue | 6.04M | 7.79M | 39.92M | 14.28M | 18.18M | 24.08M |
| Long-Term Deferred Tax Liabilities | 823.00K | 810.00K | 1.08M | 841.00K | 1.05M | 4.33M |
| Other Long-Term Liabilities | 1.11M | 1.22M | 7.84M | 1.06M | 961.00K | 882.00K |
| Total Liabilities | 87.25M | 143.46M | 140.62M | 159.87M | 160.52M | 180.62M |
| Common Stock | 410.00K | 404.00K | 396.00K | 83.00K | 80.00K | 77.00K |
| Additional Paid-In Capital | 1.75B | 1.73B | 1.70B | 860.82M | 847.01M | 831.42M |
| Retained Earnings | -1.16B | -1.26B | -1.19B | -1.00B | -926.10M | -736.00M |
| Treasury Stock | -46.47M | -46.47M | -46.47M | -5.98M | -563.00K | |
| Comprehensive Income & Other | 1.18M | -1.49M | 1.23M | -2.22M | -1.90M | -907.00K |
| Total Common Equity | 539.97M | 424.29M | 471.72M | -148.05M | -81.47M | 94.60M |
| Shareholders' Equity | 539.97M | 424.29M | 471.72M | 163.20M | 229.79M | 94.60M |
| Total Liabilities & Equity | 627.22M | 567.75M | 612.35M | 323.07M | 390.31M | 275.21M |
| Total Debt | 28.09M | 30.83M | 30.70M | 98.21M | 102.66M | 111.65M |
| Net Cash (Debt) | 448.63M | 156.75M | 262.18M | 16.68M | 63.13M | -83.20M |
| Net Cash Per Share | 1.16 | 0.41 | 0.74 | 0.21 | 0.81 | -1.10 |
| Filing Date Shares Outstanding | 392.58M | 390.07M | 378.99M | 290.12M | 79.06M | 77.20M |
| Total Common Shares Outstanding | 392.12M | 386.38M | 377.53M | 80.23M | 79.48M | 76.92M |
| Working Capital | 460.06M | 345.96M | 309.99M | 48.89M | 165.37M | 22.50M |
| Book Value Per Share | 1.38 | 1.10 | 1.25 | -1.85 | -1.02 | 1.23 |
| Tangible Book Value | 539.97M | 424.29M | 471.72M | -255.77M | -200.90M | -40.97M |
| Tangible Book Value Per Share | 1.38 | 1.10 | 1.25 | -3.19 | -2.53 | -0.53 |
| Buildings | 1.76M | 1.71M | ||||
| Machinery | 38.60M | 39.37M | 43.26M | 41.80M | 39.12M | 38.09M |
| Construction In Progress | 560.00K | 900.00K | 6.03M | 2.33M | 1.61M | 4.55M |
| Leasehold Improvements | 13.78M | 14.05M | 13.75M | 13.79M | 12.23M | 12.10M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 84.91M | -74.90M | -138.88M | -74.66M | -190.10M | -59.24M |
| Depreciation & Amortization | 9.56M | 10.98M | 16.86M | 15.18M | 15.03M | 3.65M |
| Other Amortization | 12.54M | |||||
| Loss (Gain) From Sale of Assets | -172.29M | |||||
| Asset Writedown & Restructuring Costs | 3.53M | |||||
| Loss (Gain) From Sale of Investments | -955.00K | -2.04M | -7.43M | -1.26M | -674.00K | |
| Stock-Based Compensation | 27.09M | 29.61M | 31.73M | 13.12M | 14.88M | 16.10M |
| Other Operating Activities | 14.54M | 6.98M | -16.53M | 6.30M | 86.56M | 2.81M |
| Change in Accounts Receivable | 326.00K | -1.36M | 8.97M | -2.99M | 1.06M | 6.73M |
| Change in Inventory | 208.00K | -11.52M | -9.88M | -4.91M | -8.47M | -4.78M |
| Change in Accounts Payable | 2.04M | 2.44M | -12.97M | 1.62M | -2.78M | 1.28M |
| Change in Unearned Revenue | -29.81M | -1.31M | -4.14M | 884.00K | -3.47M | -3.21M |
| Change in Other Net Operating Assets | -11.74M | 4.88M | -11.16M | 3.33M | -4.95M | -19.95M |
| Operating Cash Flow | -80.30M | -74.34M | -143.45M | -43.29M | -89.37M | -44.06M |
| Capital Expenditures | -2.28M | -8.30M | -8.36M | -2.83M | -3.83M | -13.26M |
| Cash Acquisitions | 278.65M | |||||
| Investment in Securities | -190.16M | 40.71M | 92.88M | 23.07M | -84.30M | |
| Other Investing Activities | -5.00M | -5.00M | 1.32M | |||
| Investing Cash Flow | 190.78M | 27.41M | 363.17M | 20.24M | -88.13M | -11.95M |
| Short-Term Debt Issued | 6.84M | |||||
| Long-Term Debt Issued | 25.00M | 10.00M | ||||
| Total Debt Issued | 25.00M | 16.84M | ||||
| Long-Term Debt Repaid | -63.19M | -2.08M | -6.84M | -501.00K | ||
| Net Debt Issued (Repaid) | -63.19M | -2.08M | 18.16M | 16.34M | ||
| Issuance of Common Stock | 944.00K | 1.05M | 2.07M | 827.00K | 917.00K | 1.49M |
| Repurchase of Common Stock | -614.00K | -484.00K | -40.95M | -5.55M | -774.00K | -1.79M |
| Other Financing Activities | -545.00K | -12.55M | -79.00K | |||
| Financing Cash Flow | 330.00K | 570.00K | -102.62M | -6.81M | 230.76M | 15.96M |
| Foreign Exchange Rate Adjustments | 106.00K | 842.00K | -785.00K | 34.00K | -404.00K | -21.00K |
| Net Cash Flow | 110.91M | -45.52M | 116.32M | -29.82M | 52.86M | -40.07M |
| Free Cash Flow | -82.58M | -82.65M | -151.81M | -46.12M | -93.19M | -57.33M |
| Free Cash Flow Margin | -97.61% | -96.85% | -166.81% | -43.37% | -95.15% | -43.90% |
| Free Cash Flow Per Share | -0.21 | -0.22 | -0.43 | -0.58 | -1.19 | -0.76 |
| Levered Free Cash Flow | 176.58M | -171.83M | -54.61M | -9.27M | -39.97M | -31.59M |
| Unlevered Free Cash Flow | 176.60M | -171.82M | -52.54M | -6.42M | -37.26M | -29.82M |
| Cash Interest Paid | 9.00K | 15.00K | 3.09M | 3.82M | 3.49M | 3.15M |
| Cash Income Tax Paid | -73.00K | 607.00K | 801.00K | 309.00K | 2.08M | |
| Change in Working Capital | -39.09M | -44.98M | -29.20M | -1.97M | -18.59M | -19.93M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 239.47M | 492.24M | 651.45M | 175.46M | 92.78M | 299.82M |
| Enterprise Value | -209.16M | 324.73M | 374.60M | 457.59M | 321.96M | 375.60M |
| Last Close Price | 0.61 | 1.28 | 1.75 | 2.21 | 1.17 | 3.92 |
| PS Ratio | 2.83 | 5.77 | 7.16 | 1.65 | 0.95 | 2.30 |
| PB Ratio | 0.44 | 1.16 | 1.38 | 1.07 | 0.40 | 3.17 |
| P/TBV Ratio | 0.44 | 1.16 | 1.38 | |||
| EV/Sales Ratio | 3.81 | 4.12 | 4.30 | 3.29 | 2.88 | |
| Debt / Equity Ratio | 0.05 | 0.07 | 0.07 | 0.60 | 0.45 | 1.18 |
| Net Debt / Equity Ratio | -0.83 | -0.37 | -0.56 | -0.10 | -0.28 | 0.88 |
| Net Debt / EBITDA Ratio | 8.45 | 1.90 | 3.74 | 0.35 | 0.75 | -1.30 |
| Net Debt / FCF Ratio | 5.43 | 1.90 | 1.73 | 0.36 | 0.68 | -1.45 |
| Asset Turnover | 0.14 | 0.14 | 0.20 | 0.30 | 0.29 | 0.43 |
| Inventory Turnover | 2.03 | 2.10 | 2.23 | 2.66 | 2.88 | 4.89 |
| Quick Ratio | 8.67 | 1.86 | 4.67 | 1.23 | 4.21 | 0.94 |
| Current Ratio | 9.10 | 4.19 | 5.70 | 1.45 | 4.81 | 1.45 |
| Return on Equity (ROE) | -11.18% | -13.13% | -28.65% | -37.99% | -117.21% | -50.71% |
| Return on Assets (ROA) | -6.61% | -9.88% | -11.63% | -11.05% | -18.61% | -14.06% |
| Return on Capital Employed (ROCE) | -11.00% | -20.30% | -15.90% | -29.50% | -28.60% | -29.90% |
| Earnings Yield | 35.99% | -15.21% | -21.32% | -42.55% | -204.90% | -19.76% |
| FCF Yield | -34.48% | -16.79% | -23.30% | -26.28% | -100.45% | -19.12% |
| Buyback Yield / Dilution | -2.76% | -8.03% | -346.24% | -1.09% | -3.32% | -5.19% |